NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
JAPIC ID: JapicCTI-121968

Registered date:

Basic Information

Recruitment status
Health condition(s) or Problem(s) studiedProphylaxis of new type of influenza virus infection
Date of first enrollment21/9/2012
Target sample size800
Countries of recruitment
Study typeINTERVENTIONAL
Intervention(s)Intervention name : KIB-PCI Dosage And administration of the intervention : intramuscular Control intervention name : egg-derived influenza A (H5N1) vaccine Dosage And administration of the control intervention : intramuscular

Outcome(s)

Primary OutcomeSRH antibody titer against H5 antigen
Secondary OutcomeHI antibody titer against H5 antigen Neutralizing antibody titer against H5N1 influenza virus

Key inclusion & exclusion criteria

Age minimum20
Age maximum64
GenderBOTH
Include criteria1) Japanese healthy adult volunteers
Exclude criteria1) Subjects with a history of influenza A (H5N1) virus infection 2) Subjects who have received influenza A (H5N1) vaccine

Related Information

Contact

public contact
Name DAIICHI SANKYO Co.,Ltd. Contact for Clinical Trial Information
Address http://www.daiichisankyo.co.jp/corporate/rd/measure/clinical/index.html
Telephone
E-mail
Affiliation
scientific contact
Name
Address
Telephone
E-mail
Affiliation